https://www.selleckchem.com/products/e6446.html
60, 95% CI 0.47-0.76) and higher rates of gastrointestinal bleeding (HR 1.30 95% CI 1.14-1.5 when compared to warfarin. Based on real-life experience, dabigatran can offer an alternative to warfarin in elderly patients, with fewer intracranial bleeding events. However, caution is warranted for gastrointestinal bleeding. To compare the efficacy and safety of dual antiplatelet therapy (DAPT) and triple therapy (TT, dual antiplatelet plus warfarin) in patients with myocardial infarction (MI) or PCI with stenting (PCI-S) who also require ch
Like
Comment
Share
